Table 5.
Post-assay Physician Recommendations | Post-assay Patient Decisions | ||||
---|---|---|---|---|---|
Observation | 5FU-based monotherapy | 5FU + Oxaliplatin | Other | Total | |
Observation | 98 70.5% |
0 | 0 | 0 | 98 70.5% |
5FU-based monotherapy | 0 | 16 11.5% |
0 | 1 0.7% |
17 12.2% |
5FU +Oxaliplatin | 5 3.6% |
1 0.7% |
15 10.8% |
1 0.72 |
22 15.8% |
Other | 1 0.7% |
0 | 0 | 1 0.72 |
2 1.4% |
Total | 104 74.8% |
17 12.2% |
15 10.8% |
3 2.2% |
139 100.0% |